ArticleBMC musculoskeletal disorders2025
Clinical characteristics and antibiotic sensitivity & resistance analysis of cases of orthopedic infections caused by Aeromonas hydrophila.
Article in BMC musculoskeletal disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Epidemiological investigation and clinical characteristics study of orthopedic infections caused by Aeromonas in the southeast coastal region from 2018 to 2024.BMC infectious diseases · 2025Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study was to elucidate the clinical characteristics and antibiotic susceptibility of orthopedic infections caused by Aeromonas hydrophila, thereby providing a suggestion for early clinical recognition and optimized managementof such infections in orthopedic clinical practice.
methodsA retrospective investigation was conducted by collecting general patient information, specimen sources, culture results, and antibiotic susceptibility data from 58 cases of Aeromonas hydrophila infections treated at our hospital between November 2020 and April 2024.
resultsThe 58 patients with Aeromonas hydrophila infections had a mean age of (50.05 ± 14.97) years, and the majority were workers. 56 cases were associated with traumatic open wounds, with injuries primarily caused by mechanical crushing or lacerations. The patients had an average hospital stay of approximately 33.97 days and underwent an average of 2.66 surgical procedures. In 5.17% of the cases, due to severe limb damage rendering replantation impossible, emergency amputations were performed shortly after admission. 23 cases eventually met the clinical cure criteria, and after improvement, were discharged; however, 5 cases experienced recurrences. 18 cases were monomicrobial A. hydrophila infections, while the remaining 40 cases showed polymicrobial involvement with at least one additional pathogen. Antibiotic susceptibility tests indicated low resistance rates of A. hydrophila to amikacin, aztreonam, cefpirome, and cefoperazone, whereas resistance rates to cefazolin and ampicillin were higher, with all specimens being resistant to ampicillin.
conclusionOrthopedic infections caused by Aeromonas hydrophila predominantly affect middle-aged male industrial and agricultural workers, with the infection risk strongly associated with environmental exposure complexity during injury, particularly during mechanical operations and farming activities. Once infected, the disease progresses rapidly and severely, necessitating multiple surgical interventions. For antibiotic therapy, aminoglycosides and third- or fourth-generation cephalosporins are recommended treatment options, whereas first-generation cephalosporins should be avoided as first-line anti-infective agents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.